topic
Good news about Medical research
Positive stories about Medical research, gathered from the newsrooms Rally reads. Every headline links back to the publisher who reported it.
7 stories.
PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis
A new treatment, nemolizumab, has shown lasting relief from itching, better sleep, and improved quality of life for children aged 2 to 11 with severe eczema. The results, sustained for a year, offer hope for families with limited treatment options. The findings will be shared at a pediatric dermatology conference.
Financial Post
Impulse Dynamics® Presented Real-World, Late-Breaking Data Revealing Heart Failure Hospitalization Reduction and Sustained Clinical Benefits of CCM® Therapy at One Year
A new study shows that CCM® Therapy significantly reduces hospitalizations for heart failure patients and provides lasting clinical benefits after one year. The results, presented at a major medical conference, offer hope for better long-term outcomes for those living with this serious condition.
Financial Post
One doctor’s fight to make IUD placement better
A doctor is working to improve the process of placing IUDs, making this highly effective form of birth control more accessible. The effort could help more people use a reliable, long-term contraceptive option. This is good news for anyone seeking better reproductive health care.
Scientific American
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
Agenus reports that its combination therapy for recurrent ovarian cancer maintained a 48% estimated three-year survival rate, offering hope for a heavily pretreated population. Nearly three-quarters of patients had platinum-resistant or refractory cancer, making the results particularly meaningful. The durable benefit extends evidence of long-term effectiveness in a difficult-to-treat group.
Financial Post
HIV Cure Research Advances as Immune Therapy Controls Virus
Groundbreaking immune therapy is now controlling HIV in patients, marking a significant step toward a cure. This research offers hope to those living with the virus, bringing the world closer to ending a long-standing health challenge. The progress highlights the potential for new treatments to transform lives.
Bloomberg
EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences
Galderma will share new research on skin diseases, longevity, and patient experiences at the 2026 EADV Congress, including long-term data on its Nemluvio treatment. The findings aim to improve understanding and care for dermatology patients. This progress highlights ongoing innovation in skin health.
Financial Post
Non-Invasive Brain Stimulation 'Significantly' Improves Depression in Just 10 Days, Trial Finds
Major depressive disorder is the most common mental health issue in the world, affecting hundreds of millions of people at some point in their lives. Even worse, a significant number are unable to find treatments that work for them.
ScienceAlert
